Discovery – Hexis Lab Pro.X®
Our in-sillico screening platform is built on proprietary deep learning algorithms. These capabilities enable us to quickly and cost-effectively design, validate and virtually prototype new bio-based products for different applications. Ingredients are systematically screened against the library of known materials in our integrated -omic databases for known bioactivities and predicted activities using machine learning.
- Identify new biological targets from -omic data
- Assess the polypharmacology and interactions of new compounds/materials across biological networks
- Mining of biomedical literature, patents, and public database to discover new properties of ingredient for optimal formulations.